Unity Biotechnology, Inc. (UBX) Misses Q1 EPS by 59c
Tweet
Share
E-mailGet Alerts UBX Hot Sheet
Join SI Premium – FREE
Unity Biotechnology, Inc. (NASDAQ: UBX) reported Q1 EPS of ($0.76), $0.59 worse than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Unity Biotechnology, Inc. (UBX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Orosur Mining launches private placement targeting C$14M
- AutoZone (AZO) Tops Q4 EPS by $1.76, Misses on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
